IRIDEX Corporation IRIX
0.50 USD -0.20 (-28.53%)
Regular-session close
0.47 -0.03 -6.00%
After hours · Nov 18, 4:40 PM ET
0.47 Day range 0.5299
0.47 52-week range 1.65
- YTD
- -56.14%
- 1 year
- -46.24%
News
benzinga.com Crude Oil Down Over 4%; Target Earnings Top Views U.S. stocks mostly fell, led by a 1.32% Dow drop. Target beat estimates and raised guidance; TJX and Bellring rallied, while oil and metals slid.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Akanda (NASDAQ:AKAN) shares rose 66.8% to $3.42 during Wednesday's regular session. The market value of their outstanding shares is at $5.4 million. Cue Biopharma (NASDAQ:CUE) shares rose…
benzinga.com Dow Falls Over 300 Points; Nvidia Posts Upbeat Earnings U.S. stocks fell as the Dow slid 300+ points; Nvidia beat Q3 estimates, while energy, commodities and European markets declined.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock moved upwards by 21.2% to $0.5 during Wednesday's pre-market session. The company's market cap stands at $7.6 million. As per the press release, Q3…
benzinga.com Why Pony AI Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket Pony AI rose 10.6% after beating Q3 loss estimates but missing sales; Autozi led gainers, while IRIDEX fell 17.6% on results and guidance.
benzinga.com Ardent Health Stock Tumbles 14.61% After Hours: Here's Why Ardent Health shares slide after hours following $14.50 secondary offering pricing and concurrent share repurchase.
benzinga.com Iridex (NASDAQ: IRIX) Shares Fall 26.96% After Hours: What Investors Should Know Iridex falls after hours as revenue misses estimates and 2026 outlook is lowered.
seekingalpha.com IRIDEX Corporation (IRIX) Q3 2026 Earnings Call Transcript IRIDEX Corporation (IRIX) Q3 2026 Earnings Call Transcriptbenzinga.com Iridex Lowers FY2026 Sales Guidance from $51.000M-$53.000M to $46.000M-$48.000M vs $52.521M Est Iridex (NASDAQ:IRIX) lowers FY2026 sales outlook from $51.000 million-$53.000 million to $46.000 million-$48.000 million vs $52.521 million estimate.
globenewswire.com Iridex Reports Third Quarter 2026 Financial Results SAN JOSE, Calif., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader in innovative laser-based medical systems, delivery devices, and accessories for the…
defenseworld.net Contrasting IRIDEX (NASDAQ:IRIX) and Medtronic (NYSE:MDT) IRIDEX (NASDAQ: IRIX - Get Free Report) and Medtronic (NYSE: MDT - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the…
globenewswire.com Iridex to Report Third Quarter 2026 Financial Results on November 17, 2026 SAN JOSE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader in innovative laser-based medical systems, delivery devices, and accessories for the…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers SciSparc (NASDAQ:SPRC) shares moved upwards by 39.4% to $1.52 during Monday's pre-market session. Xencor (NASDAQ:XNCR) stock moved upwards by 29.46% to $32.6. The company's market cap stands…
defenseworld.net IRIDEX (NASDAQ:IRIX) Stock: Insider Shih-Yao David Lin Acquires 10,000 Shares IRIDEX Corporation (NASDAQ: IRIX - Get Free Report) major shareholder Shih-Yao David Lin purchased 10,000 shares of IRIDEX stock in a transaction dated Thursday, October 16th. The shares were…
globenewswire.com Iridex Completes Relocation of Manufacturing Facility to San Jose, California Company Expects to Realize Approximately $600,000 in Annualized Cost Savings Company Expects to Realize Approximately $600,000 in Annualized Cost Savings
defenseworld.net IRIDEX (NASDAQ:IRIX) Shares Cross Below 200-Day Moving Average – Here’s Why IRIDEX Corporation (NASDAQ: IRIX - Get Free Report) crossed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $0.98 and traded as…
zacks.com IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15% IRIX's Q2 loss per share widens year over year and revenues decline as Middle East disruptions and reduced sell-through in China weigh on retina sales, offsetting continued growth in the Cyclo G6…
seekingalpha.com IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript
globenewswire.com Iridex Reports Second Quarter 2026 Financial Results MOUNTAIN VIEW, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…
globenewswire.com Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026 MOUNTAIN VIEW, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…
globenewswire.com Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering MOUNTAIN VIEW, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…
globenewswire.com Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference MOUNTAIN VIEW, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…
zacks.com IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth IRIDEX posts a narrower year-over-year net loss per share in Q1'26 as strong glaucoma product sales and lower operating costs helped offset weakness in retina sales and supply-chain disruptions.
seekingalpha.com IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript
globenewswire.com Iridex Reports First Quarter 2026 Financial Results MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…
globenewswire.com Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 MOUNTAIN VIEW, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…
globenewswire.com Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology MOUNTAIN VIEW, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and…
zacks.com Iridex's Q4 Loss Narrows Year Over Year on Retina Sales Growth IRIX incurs narrower year-over-year loss per share in Q4 as growth in retina systems and glaucoma probes boosts revenues, though margins remain pressured by higher costs.
seekingalpha.com IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript IRIDEX Corporation (IRIX) Q4 2025 Earnings Call Transcript
